These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 37243143)

  • 21. Mutation of the N-Terminal Region of Chikungunya Virus Capsid Protein: Implications for Vaccine Design.
    Taylor A; Liu X; Zaid A; Goh LY; Hobson-Peters J; Hall RA; Merits A; Mahalingam S
    mBio; 2017 Feb; 8(1):. PubMed ID: 28223458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Factor I-Like Activity Associated with Chikungunya Virus Contributes to Its Resistance to the Human Complement System.
    Nag J; Mukesh RK; Suma SM; Kunnakkadan U; Kumar NA; Johnson JB
    J Virol; 2020 Mar; 94(7):. PubMed ID: 31941783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High throughput proteomic analysis and a comparative review identify the nuclear chaperone, Nucleophosmin among the common set of proteins modulated in Chikungunya virus infection.
    Abraham R; Mudaliar P; Jaleel A; Srikanth J; Sreekumar E
    J Proteomics; 2015 Apr; 120():126-41. PubMed ID: 25782748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA Damage Response Signaling Is Crucial for Effective Chikungunya Virus Replication.
    Chatterjee S; Kumar S; Mamidi P; Datey A; Sengupta S; Mahish C; Laha E; De S; Keshry SS; Nayak TK; Ghosh S; Singh S; Subudhi BB; Chattopadhyay S; Chattopadhyay S
    J Virol; 2022 Dec; 96(23):e0133422. PubMed ID: 36377875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interferon Alpha, but Not Interferon Beta, Acts Early To Control Chronic Chikungunya Virus Pathogenesis.
    Locke MC; Fox LE; Dunlap BF; Young AR; Monte K; Lenschow DJ
    J Virol; 2022 Jan; 96(1):e0114321. PubMed ID: 34668781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interferon-alpha/beta deficiency greatly exacerbates arthritogenic disease in mice infected with wild-type chikungunya virus but not with the cell culture-adapted live-attenuated 181/25 vaccine candidate.
    Gardner CL; Burke CW; Higgs ST; Klimstra WB; Ryman KD
    Virology; 2012 Apr; 425(2):103-12. PubMed ID: 22305131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chikungunya virus infection results in higher and persistent viral replication in aged rhesus macaques due to defects in anti-viral immunity.
    Messaoudi I; Vomaske J; Totonchy T; Kreklywich CN; Haberthur K; Springgay L; Brien JD; Diamond MS; Defilippis VR; Streblow DN
    PLoS Negl Trop Dis; 2013; 7(7):e2343. PubMed ID: 23936572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proteomic profiling of chikungunya virus-infected human muscle cells: reveal the role of cytoskeleton network in CHIKV replication.
    Issac TH; Tan EL; Chu JJ
    J Proteomics; 2014 Aug; 108():445-64. PubMed ID: 24933005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Infection of myofibers contributes to increased pathogenicity during infection with an epidemic strain of chikungunya virus.
    Rohatgi A; Corbo JC; Monte K; Higgs S; Vanlandingham DL; Kardon G; Lenschow DJ
    J Virol; 2014 Mar; 88(5):2414-25. PubMed ID: 24335291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Replication and innate immune responses of two chikungunya virus genotypes in human monocyte-derived macrophages.
    Lau JZH; Chua CL; Chan YF; Nadarajan VS; Lee CLL; Sam IC
    J Gen Virol; 2023 Apr; 104(4):. PubMed ID: 37043371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic joint disease caused by persistent Chikungunya virus infection is controlled by the adaptive immune response.
    Hawman DW; Stoermer KA; Montgomery SA; Pal P; Oko L; Diamond MS; Morrison TE
    J Virol; 2013 Dec; 87(24):13878-88. PubMed ID: 24131709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. UBXN3B Controls Immunopathogenesis of Arthritogenic Alphaviruses by Maintaining Hematopoietic Homeostasis.
    Geng T; Yang D; Lin T; Cahoon JG; Wang P
    mBio; 2022 Dec; 13(6):e0268722. PubMed ID: 36377866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Establishment and Comparison of Pathogenicity and Related Neurotropism in Two Age Groups of Immune Competent Mice, C57BL/6J Using an Indian Isolate of Chikungunya Virus (CHIKV).
    Jain J; Narayanan V; Kumar A; Shrinet J; Srivastava P; Chaturvedi S; Sunil S
    Viruses; 2019 Jun; 11(6):. PubMed ID: 31242674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Host oxidative folding pathways offer novel anti-chikungunya virus drug targets with broad spectrum potential.
    Langsjoen RM; Auguste AJ; Rossi SL; Roundy CM; Penate HN; Kastis M; Schnizlein MK; Le KC; Haller SL; Chen R; Watowich SJ; Weaver SC
    Antiviral Res; 2017 Jul; 143():246-251. PubMed ID: 28461071
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chikungunya Virus Replication Rate Determines the Capacity of Crossing Tissue Barriers in Mosquitoes.
    Merwaiss F; Filomatori CV; Susuki Y; Bardossy ES; Alvarez DE; Saleh MC
    J Virol; 2021 Jan; 95(3):. PubMed ID: 33148794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chikungunya virus host range E2 transmembrane deletion mutants induce protective immunity against challenge in C57BL/6J mice.
    Piper A; Ribeiro M; Smith KM; Briggs CM; Huitt E; Nanda K; Spears CJ; Quiles M; Cullen J; Thomas ME; Brown DT; Hernandez R
    J Virol; 2013 Jun; 87(12):6748-57. PubMed ID: 23552427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Antiviral Alkaloid Berberine Reduces Chikungunya Virus-Induced Mitogen-Activated Protein Kinase Signaling.
    Varghese FS; Thaa B; Amrun SN; Simarmata D; Rausalu K; Nyman TA; Merits A; McInerney GM; Ng LFP; Ahola T
    J Virol; 2016 Nov; 90(21):9743-9757. PubMed ID: 27535052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High level of vector competence of Aedes aegypti and Aedes albopictus from ten American countries as a crucial factor in the spread of Chikungunya virus.
    Vega-Rúa A; Zouache K; Girod R; Failloux AB; Lourenço-de-Oliveira R
    J Virol; 2014 Jun; 88(11):6294-306. PubMed ID: 24672026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Host Factor Nucleophosmin 1 (NPM1/B23) Exerts Antiviral Effects against Chikungunya Virus by Its Interaction with Viral Nonstructural Protein 3.
    Pradeep P; Sivakumar KC; Sreekumar E
    Microbiol Spectr; 2023 Aug; 11(4):e0537122. PubMed ID: 37409962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Tetraspanin CD81 Is a Host Factor for Chikungunya Virus Replication.
    Lasswitz L; Zapatero-Belinchón FJ; Moeller R; Hülskötter K; Laurent T; Carlson LA; Goffinet C; Simmons G; Baumgärtner W; Gerold G
    mBio; 2022 Jun; 13(3):e0073122. PubMed ID: 35612284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.